-
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Rating of "Moderate Buy" by Brokerages
Source: Buzz FX / 07 Oct 2024 03:11:11 America/New_York
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat October 7, 2024 Share Link copied to clipboard. Shares of Neurocrine Biosciences, Inc.
Read more...